CLPT SEC Filings: 8-K, 10-Q, S-3 & 424B – ClearPoint Neuro

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 28, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 13, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 17, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

News

TYPE

HEADLINE

FILED AT

8-K

ClearPoint Neuro Reports Third Quarter 2026 Results with 36% Revenue Growth to $12.1 Million

Oct 28, 2026

8-K

ClearPoint Neuro Reports Q2 2026 Financial Results and Strategic Updates

Aug 3, 2026

8-K

ClearPoint Neuro, Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 21, 2026

8-K

ClearPoint Neuro Reports Record First Quarter 2026 Revenue of $12.1 Million

May 13, 2026

8-K

ClearPoint Neuro Reports Record 2025 Financial Results and Strategic Expansion

Mar 17, 2026

8-K/A

IRRAS Holdings, Inc. Consolidated Financial Statements as of September 30, 2025

Feb 5, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

SHARE RESALE REGISTRATION | Shares: 1,312,570

Jan 22, 2026

424B5

REGISTERED OFFERING

May 12, 2025

424B5

ATM | Offering amount: $50,000,000

Nov 7, 2024

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Mar 1, 2024

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 28, 2024

424B5

1,850,140 Shares-

Feb 19, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 20, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 9, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 5, 2026

S-3

SHARE RESALE REGISTRATION

Jan 14, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 4, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 16, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 23, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 10, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 9, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 5, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 14, 2023

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 3, 2023

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

BIGGER CAPITAL FUND L P (Filed by)

Nov 3, 2026

Richards Timothy T. (Reporting)

Oct 2, 2026

FLETCHER R JOHN (Reporting)

Oct 2, 2026

BURNETT JOSEPH (Reporting)

Sep 3, 2026

SCHEDULE 13G/A

MAK CAPITAL ONE LLC (Filed by)

Aug 12, 2026

SCHEDULE 13G/A

BIGGER CAPITAL FUND L P (Filed by)

Aug 4, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Jan 27, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 23, 2026

CORRESP

Form CORRESP - Correspondence

Jan 20, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Nov 21, 2023

CORRESP

Form CORRESP - Correspondence

Nov 17, 2023

LETTER

Form UPLOAD - SEC-generated letter

Nov 16, 2023

ClearPoint Neuro, Inc. CLPT · SEC Filings